Chava Chezar-Azerrad

Chava Chezar-Azerrad practices at Luminis Health Doctors Community Medical Center in Lanham, Maryland, part of Luminis Health.

Chava Chezar-Azerrad's NPI, 1366905366, was assigned on April 8, 2019. Chava Chezar-Azerrad holds ZZ license 115500.

Chava Chezar-Azerrad's primary practice is Luminis Health Doctors Community Medical Center, at 8118 Good Luck Road, Lanham, MD 20706 in Prince Georges County. The practice phone is (301) 552-8118.

Chava Chezar-Azerrad's primary practice is Luminis Health Doctors Community Medical Center in Lanham, Maryland, part of Luminis Health. Chava Chezar-Azerrad is also affiliated with MedStar Washington Hospital Center. The medical group on file is Capitol Cardiology Associates. Dmand AI also links Chava Chezar-Azerrad to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chava Chezar-Azerrad practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Chava Chezar-Azerrad's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Chava Chezar-Azerrad is licensed in ZZ.

CMS data shows 1,751 Medicare services from Chava Chezar-Azerrad across 20 procedure codes in 2024, for 716 Medicare patients. Medicare paid $107,113 for them.

CMS counts 716 Medicare patients who saw Chava Chezar-Azerrad in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chava Chezar-Azerrad's median patient age at 68, with 52% women.

In 2024, Chava Chezar-Azerrad wrote 217 Medicare Part D claims for 58 patients. 91% of them were for generic drugs. CMS names the drug for 138 of them, across 7 drugs with 11 or more claims each, at $1,298 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Chava Chezar-Azerrad for performance year 2024, reported as part of a group. Chava Chezar-Azerrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Chava Chezar-Azerrad as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 102 general payments to Chava Chezar-Azerrad from 27 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $323.